REC Interventional Cardiology English Ed最新文献

Impella-Clip: a secure and effective strategy in cardiogenic shock due to acute severe mitral regurgitation. Case resolution 叶轮夹:急性严重二尖瓣反流所致心源性休克的一种安全有效的治疗策略。案例解析

REC Interventional Cardiology English Ed Pub Date : 2023-11-06 DOI: 10.24875/recice.m22000319

Clara Ugueto-Rodrigo, Alfonso Jurado-Román, Lucía Fernández-Gassó, Guillermo Galeote-García, and, Raúl Moreno

引用次数: 0

New TAVI technique for difficult valve crossing 新TAVI技术解决阀门交叉困难

REC Interventional Cardiology English Ed Pub Date : 2023-11-06 DOI: 10.24875/recice.m23000378

José M. de la Torre Hernández, Gabriela Veiga Fernández, Sergio Barrera, Fermín Sainz Laso, Dae-Hyun Lee, and Tamara García Camarero

引用次数: 0

Marking a milestone. REC: Interventional Cardiology assigned its first impact factor 这是一个里程碑。REC:介入心脏病学分配了第一个影响因子

REC Interventional Cardiology English Ed Pub Date : 2023-11-06 DOI: 10.24875/recice.m23000405

José M. de la Torre-Hernández, Fernando Alfonso, Raúl Moren, Soledad Ojeda, Armando Pérez de Prado, and, Rafael Romaguera

引用次数: 0

Cardiac catheterization activity in pediatric cardiac transplantation. Can catheterization needs be predicted? 儿童心脏移植的心导管插入术活动。导尿需求可以预测吗?

REC Interventional Cardiology English Ed Pub Date : 2023-11-02 DOI: 10.24875/recice.m23000415

Andrea Freixa-Benavente, Paola Dolader, Ferran Gran, and, Pedro Betrián-Blasc

{"title":"Cardiac catheterization activity in pediatric cardiac transplantation. Can catheterization needs be predicted?","authors":"Andrea Freixa-Benavente, Paola Dolader, Ferran Gran, and, Pedro Betrián-Blasc","doi":"10.24875/recice.m23000415","DOIUrl":"https://doi.org/10.24875/recice.m23000415","url":null,"abstract":"Introduction and objectives : Although cardiac catheterization (CC) has become a routine practice in pediatric heart transplantation (HT), there is still a shortage of widely used protocols and strong evidence on the number of procedures required and their impact on HT outcomes, as well as the need for further CC. This study aimed to analyze CC activity in pediatric HT recipients in a tertiary center and describe risk factors for a higher number of post-HT procedures. Methods : This retrospective study obtained data from medical reports and image files. The sample was composed of patients with cardiomyopathies and congenital heart diseases (CHD). Risk factor analysis for CCs was conducted with linear regression and the ANOVA test. Results : The sample included 61 children (36.07% with CHD). The CHD group had a higher mean number of CCs prior to HT. The most frequent activities prior to HT were diagnostic catheterizations, followed by endomyocardial biopsies for cardiomyopathies and aortopulmonary collaterals in CHD patients. There were 389 post-HT CCs (608 procedures). Most CCs were performed for rejection surveillance, accounting for 92.75% of procedures. The univentricular CHD subgroup was associated with a higher number of CC after HT ( P = .03). Conclusions : Despite long life expectancy, pediatric HT recipients have substantial morbidity due to these procedures. Therefore, it is necessary to establish protocols for follow-up and rejection surveillance to minimize the interventions required by these patients.","PeriodicalId":34613,"journal":{"name":"REC Interventional Cardiology English Ed","volume":"8 20","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135973239","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

The PULSTA valve in native right ventricular outflow tract: initial experience in 3 Spanish hospitals 原发性右心室流出道的PULSTA瓣膜:西班牙3家医院的初步经验

REC Interventional Cardiology English Ed Pub Date : 2023-10-30 DOI: 10.24875/recice.m23000402

Diana Salas-Mera, César Abelleira Pardeiro, Enrique José Balbacid Domingo, Adolfo Sobrino Baladrón, José Luis Zunzunegui Martínez, Fernando Sarnago Cebada, and, Federico Gutiérrez-Larraya Aguado

{"title":"The PULSTA valve in native right ventricular outflow tract: initial experience in 3 Spanish hospitals","authors":"Diana Salas-Mera, César Abelleira Pardeiro, Enrique José Balbacid Domingo, Adolfo Sobrino Baladrón, José Luis Zunzunegui Martínez, Fernando Sarnago Cebada, and, Federico Gutiérrez-Larraya Aguado","doi":"10.24875/recice.m23000402","DOIUrl":"https://doi.org/10.24875/recice.m23000402","url":null,"abstract":"Introduction and objectives: Surgery for congenital heart defects with right ventricular outflow tract (RVOT) stenosis often results in significant pulmonary regurgitation, requiring pulmonary valve replacement in the long term. Despite the development of balloon-expandable prostheses, the native RVOT frequently dilates beyond the maximum diameters allowed for these valves. To allow percutaneous pulmonary valve implantation (PPVI) in these patients, clinical trials have been initiated with self-expanding prostheses, including the PULSTA valve. The aim of this study was to report the initial experience with this valve at three Spanish hospitals. Methods: Descriptive study presenting the results of PPVI with the PULSTA prosthesis in patients with native RVOT and pulmonary regurgitation. Results: We included 10 patients with a mean age of 15 ± 2.8 years. The implantation was successful in all patients, with no major complications occurring during the procedure. The mean length of follow-up was 18 [range, 2-35] months. In 8 patients, cardiac magnetic resonance was performed at 6 months, revealing a reduction in mean end-diastolic volume (131.7 ± 31.7 mL/m 2 vs 100.3 ± 28.9 mL/m 2 ) and end-systolic volume (68 ± 20.8 mL/m 2 vs 57 ± 18.5 mL/m 2 ). Conclusions: The PULSTA prosthesis offers a safe, feasible, and effective alternative for PPVI in patients with native dilated RVOT. Due to the limited available follow-up data, further studies are needed to assess its long-term safety and durability.","PeriodicalId":34613,"journal":{"name":"REC Interventional Cardiology English Ed","volume":"115 4","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136068305","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Implantation of a pulmonary bioprosthetic valve in a single pulmonary artery 在单根肺动脉内植入肺生物瓣膜

REC Interventional Cardiology English Ed Pub Date : 2023-10-30 DOI: 10.24875/recice.m23000407

Luis Fernández González, Roberto Blanco Mata, Koldobika García San Román, Juan Carlos Astorga Burgo, Aída Acín Labarta, and, Josune Arriola Meabe

引用次数: 0

Impella-supported MitraClip implantation in acute mitral regurgitation 叶轮支撑MitraClip植入治疗急性二尖瓣返流

REC Interventional Cardiology English Ed Pub Date : 2023-10-23 DOI: 10.24875/recice.m23000414

Carlos Coroas Pascual, Mikel Arrizabalaga Gil, Iván Olavarri Miguel, Carmen Garrote Coloma, Isaac Pascual Calleja, and José M. de la Torre-Hernández

引用次数: 0

Effectiveness of the DyeVert Power XT system during percutaneous coronary interventions DyeVert Power XT系统在经皮冠状动脉介入治疗中的有效性

REC Interventional Cardiology English Ed Pub Date : 2023-10-23 DOI: 10.24875/recice.m23000409

Federico Vergni, Manfredi Arioti, Valentina Boasi, Federico Ariel Sánchez, Massimo Leoncini and, Fabio Ferrari

{"title":"Effectiveness of the DyeVert Power XT system during percutaneous coronary interventions","authors":"Federico Vergni, Manfredi Arioti, Valentina Boasi, Federico Ariel Sánchez, Massimo Leoncini and, Fabio Ferrari","doi":"10.24875/recice.m23000409","DOIUrl":"https://doi.org/10.24875/recice.m23000409","url":null,"abstract":"Introduction and objectives: Contrast-induced-acute kidney injury (CI-AKI) is a potential complication of angiographic procedures. The DyeVert Contrast Reduction system (Osprey Medical, United States) is a device to reduce the concentration of contrast medium (CM) in the kidneys by decreasing the amount of CM delivered to patients. Unlike manual systems, few data are available on the DyeVert Power XT system, which is used in conjunction with automated contrast injection. The main aim of our study was to evaluate its effectiveness during percutaneous coronary interventions (PCI). Methods: Between 2020 and 2022, 101 patients who underwent PCI with the DyeVert Power XT system (case group) were enrolled to evaluate the amount of CM saved through the use of this device, as well as the rate, severity, and predictors of CI-AKI. Patients who underwent PCI without the use of the device (control group) were enrolled to create a matched group allowing assessment of differences in CM and the CI-AKI rate. Results : In the case group, the amount of CM saved was 114 ± 42 mL, representing an average of 32% of the total CM. Fourteen patients (13.9%) developed CI-AKI. The only independent predictors of CI-AKI were hematocrit (OR, 0.86; 95%CI, 0.74-0.99; P = .04) and ejection fraction (OR, 0.88; 95%CI, 0.82-0.95; P = .001). As a result of diversion by the device, the amount of CM delivered was lower in the case group than in controls (252 vs 267 mL; P = .42), but this difference was nonsignificant. Equally, the reduction in CI-AKI (14.3% vs 16.3%) was nonsignificant. Conclusions: Hematocrit and ejection fraction may be more important predictors of CI-AKI than the CM volume normally used during PCI in the general population. The net practical benefit of DyeVert Power XT was low.","PeriodicalId":34613,"journal":{"name":"REC Interventional Cardiology English Ed","volume":"84 2","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135368669","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Vascular closure devices: the jury is still out 血管闭合装置:目前尚无定论

REC Interventional Cardiology English Ed Pub Date : 2023-10-23 DOI: 10.24875/recice.m23000404

Juan M. Ruiz-Nodar, and Javier Pineda Rocamora

引用次数: 0

Debate. Percutaneous revascularization in dilated cardiomyopathy. Apropos of the REVIVED BCIS2 trial: the clinician�s view 辩论。扩张型心肌病的经皮血管重建术。关于恢复BCIS2试验:临床医生的观点

REC Interventional Cardiology English Ed Pub Date : 2023-10-18 DOI: 10.24875/recice.m23000403

Ángel Manuel Iniesta Manjavacas

引用次数: 0